Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate for Treatment of Hepatitis B e Antigen-Negative Hepatitis B (China)

NCT02836236 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

155

Enrollment

INDUSTRY

Sponsor class

Conditions

HBV
Chronic HBV Infection

Interventions

DRUG: TAF
DRUG: TDF
DRUG: TAF Placebo
DRUG: TDF Placebo

Sponsor

Gilead Sciences